Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
KP Tissue Releases First Quarter 2025 Financial Results
May 14 (Reuters) - KP Tissue Inc KPT.TO:KP TISSUE RELEASES FIRST QUARTER 2025 FINANCIAL RESULTSKP TISSUE INC: TARIFF IMPACT TO OUR BUSINESS IN Q1 WAS NOT SIGNIFICANTKP TISSUE: ASSUMING A SIMILAR TARIFF ENVIRONMENT, EXPECT Q2 2025 ADJUSTED EBITDA IN RANGE OF $70 MILLION TO $75 MILLION
Reuters
Wed, May 14
Well Health Q1 Revenue CAD 294.14 Mln
May 14 (Reuters) - WELL Health Technologies Corp WELL.TO:WELL HEALTH Q1 REVENUE CAD 294.137 MILLION VERSUS. IBES ESTIMATE CAD 283.9 MILLIONWELL HEALTH Q1 ADJUSTED EBITDA CAD 27.577 MILLIONWELL HEALTH Q1 ADJUSTED GROSS MARGIN 39.9%WELL HEALTH Q1 ADJUSTED EPS CAD 0.03WELL HEALTH Q1 NET INCOME CAD -41....
Reuters
Wed, May 14
Editas Medicine Reports New In Vivo Data Highlighting The Potential Of Editas’ Gene Upregulation Strategy In Hscs At The American Society Of Gene And Cell Therapy Annual Meeting
May 14 (Reuters) - Editas Medicine Inc EDIT.O:EDITAS MEDICINE REPORTS NEW IN VIVO DATA HIGHLIGHTING THE POTENTIAL OF EDITAS’ GENE UPREGULATION STRATEGY IN HSCS AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY ANNUAL MEETING
Reuters
Wed, May 14
Pasithea Therapeutics Announces Initiation Of Phase 1/1B Study Of Pas-004 In Adult Nf1 Patients And Activation Of First Clinical Trial Site
May 14 (Reuters) - Pasithea Therapeutics Corp KTTA.O:PASITHEA THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1/1B STUDY OF PAS-004 IN ADULT NF1 PATIENTS AND ACTIVATION OF FIRST CLINICAL TRIAL SITE
Reuters
Wed, May 14
Ascot to raise $350 million to bolster balance sheet and fuel long-term growth
By Ryan HewlettMay 14 - (The Insurer) - Ascot is to raise $350 million through an offering of senior notes, which the Bermuda-based carrier said would further strengthen its balance sheet and help to fuel long-term profitable growth.The (re)insurer said in a statement on Tuesday that it has priced i...
Reuters
Wed, May 14
Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results
May 14 (Reuters) - Milestone Pharmaceuticals Inc MIST.O:MILESTONE PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES REGULATORY AND CORPORATE UPDATE
Reuters
Wed, May 14
Endava And Alixpartners Announce Partnership To Accelerate Digital Transformation
May 14 (Reuters) - ENDAVA AND ALIXPARTNERS ANNOUNCE PARTNERSHIP TO ACCELERATE DIGITAL TRANSFORMATION
Reuters
Wed, May 14
Calian Reports Results For The Second Quarter
May 14 (Reuters) - Calian Group Ltd CGY.TO:CALIAN REPORTS RESULTS FOR THE SECOND QUARTERQ2 REVENUE AT $194 MILLION, DOWN 4% YEAR-ON-YEAR: GUIDANCE WITHDRAWN DUE TO ONGOING ECONOMIC AND GEOPOLITICAL UNCERTAINTYQTRLY ADJUSTED EPS $0.93Q2 EARNINGS PER SHARE VIEW C$1.05, REVENUE VIEW C$200.8 MILLION -- ...
Reuters
Wed, May 14
Charlotte's Web Reports Year-Over-Year Growth For Q1 2025
May 14 (Reuters) - Charlotte's Web Holdings Inc CWEB.TO:CHARLOTTE'S WEB REPORTS YEAR-OVER-YEAR GROWTH FOR Q1 2025
Reuters
Wed, May 14
Charlotte's Web Reports Year-Over-Year Growth For Q1 2025
May 14 (Reuters) - Charlotte's Web Holdings Inc CWEB.TO:CHARLOTTE'S WEB REPORTS YEAR-OVER-YEAR GROWTH FOR Q1 2025
Reuters
Wed, May 14
FDA Accepts Biologics License Application For Mucopolysaccharidosis II Treatment
May 14 (Reuters) - Regenxbio Inc RGNX.O:FDA ACCEPTS BIOLOGICS LICENSE APPLICATION FOR MUCOPOLYSACCHARIDOSIS II TREATMENTREGENXBIO INC - FDA GRANTS PRIORITY REVIEW WITH PDUFA DATE NOVEMBER 9, 2025
Reuters
Wed, May 14
Intact Financial Corporation Announces Consent And Proxy Solicitation Targeting 10 Series Of Medium Term Notes
May 14 (Reuters) - Intact Financial Corp IFC.TO:INTACT FINANCIAL CORPORATION ANNOUNCES CONSENT AND PROXY SOLICITATION TARGETING 10 SERIES OF MEDIUM TERM NOTESINTACT FINANCIAL CORP - COMMENCES CONSENT AND PROXY SOLICITATION FOR $2.9 BILLION NOTES
Reuters
Wed, May 14
Local Bounti Announces First Quarter 2025 Financial Results
May 14 (Reuters) - Local Bounti Corp LOCL.N:LOCAL BOUNTI ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS
Reuters
Wed, May 14
Endava Announces Third Quarter Fiscal Year 2025 Results
May 14 (Reuters) - ENDAVA ANNOUNCES THIRD QUARTER FISCAL YEAR 2025 RESULTSQ4 FY2025 REVENUE EXPECTED £186M-£188M: Q3 REVENUE £194.8 MILLION: EXPECTS Q4 ADJUSTED DILUTED EPS TO BE IN RANGE OF £0.22 TO £0.24 PER SHAREQ4 REVENUE VIEW 205.2 MILLION STG -- LSEG IBES DATABOARD AUTHORIZES $50 MILLION SHARE...
Reuters
Wed, May 14
Southland Appoints Donald Graul As Chief Strategy Officer
May 14 (Reuters) - Southland Holdings Inc SLND.A:SOUTHLAND APPOINTS DONALD GRAUL AS CHIEF STRATEGY OFFICER
Reuters
Wed, May 14
Climb Bio Reports First Quarter 2025 Financial Results
May 14 (Reuters) - Climb Bio Inc CLYM.O:CLIMB BIO REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATESCLIMB BIO INC - BUDOPRUTUG CLINICAL TRIALS IN PMN, ITP, SLE ON TRACK FOR 2025
Reuters
Wed, May 14
Tonix Pharmaceuticals Announces Appointment Of Joseph Hand, Esq., As General Counsel And Executive Vice President Of Operations
May 14 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:TONIX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF JOSEPH HAND, ESQ., AS GENERAL COUNSEL AND EXECUTIVE VICE PRESIDENT OF OPERATIONS
Reuters
Wed, May 14
Benitec Biopharma Q3 Operating Income USD -10.2 Million
May 14 (Reuters) - Benitec Biopharma Inc BNTC.O:BENITEC BIOPHARMA Q3 OPERATING INCOME USD -10.2 MILLIONBENITEC BIOPHARMA Q3 NET INCOME USD -9.4 MILLIONBENITEC BIOPHARMA Q3 EPS USD -0.24
Reuters
Wed, May 14
RPT-BREAKINGVIEWS-CATL’s $4 bln IPO offers trade truce reality check
By Katrina Hamlin HONG KONG, May 14 (Reuters Breakingviews) - The world’s biggest IPO this year excludes U.S. onshore investors. The decision reduces geopolitical risks that loom over Chinese battery maker Contemporary Amperex Technology's 300750.SZ $4 billion Hong Kong debut. It also shields...
Reuters
Wed, May 14
RPT-BREAKINGVIEWS-UnitedHealth faces a long and painful recovery
By Robert Cyran NEW YORK, May 13 (Reuters Breakingviews) - Even UnitedHealth UNH.N will struggle to overcome parasitic medical costs that Warren Buffett once called a tapeworm eating away at U.S. economic competitiveness. The $300 billion healthcare conglomerate reinstalled Chairman Stephen Hemsl...
Reuters
Wed, May 14
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free